Position in BNTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,228,682
+$2,480,180 QoQ
Shares Held
77,686
+45.4% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#74
of 282 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026APG Asset Management N.V. holds $228,114,768 across 7 Biotechnology names. BNTX ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
234,624 | $116,544,779 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
82,164 | $51,232,540 | |
| 3 | INCY |
Incyte Corp
|
203,661 | $23,087,010 | |
| 4 | RPRX |
Royalty Pharma plc
|
227,127 | $12,735,010 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
40,803 | $9,832,298 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
130,277 | $7,454,449 | |
| 7 | BNTX |
BioNTech SE
This page
|
77,686 | $7,228,682 |
All Filings in BNTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,228,682 | 77,686 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,748,502 | 53,426 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,549,227 | 47,786 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $5,394,514 | 54,700 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,653,557 | 53,100 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,516,576 | 49,600 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $5,344,255 | 46,900 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||